Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Ann Biol Clin (Paris) ; 78(5): 555-564, 2020 10 01.
Article in French | MEDLINE | ID: mdl-33026350

ABSTRACT

Biochemical diagnosis of hereditary metabolic diseases requires the detection and simultaneous identification of a large number of compounds, hence the interest in metabolic profiles. Amino acid chromatography allows the identification and quantification of more than forty compounds. As part of the accreditation process for medical biology examinations according to standard NF EN ISO 15189, the group from SFEIM recommends an approach to accredit amino acid chromatography. Validation parameters and recommendations are discussed in this specific framework.


Subject(s)
Amino Acids/analysis , Chromatography/standards , Diagnostic Tests, Routine/standards , Metabolism, Inborn Errors/diagnosis , Accreditation/standards , Adult , Amino Acids/blood , Amino Acids/cerebrospinal fluid , Amino Acids/urine , Amniocentesis/standards , Amniotic Fluid/chemistry , Blood Chemical Analysis/methods , Blood Chemical Analysis/standards , Blood Specimen Collection/standards , Child , Chromatography/methods , Chromatography, Liquid/standards , Diagnostic Tests, Routine/methods , Female , Humans , Infant, Newborn , Metabolism, Inborn Errors/blood , Metabolism, Inborn Errors/cerebrospinal fluid , Metabolism, Inborn Errors/urine , Neonatal Screening/methods , Neonatal Screening/standards , Pre-Analytical Phase , Pregnancy , Prenatal Diagnosis/methods , Prenatal Diagnosis/standards , Tandem Mass Spectrometry/standards , Urinalysis/methods , Urinalysis/standards , Urine Specimen Collection/standards
2.
Mol Genet Genomic Med ; 7(8): e815, 2019 08.
Article in English | MEDLINE | ID: mdl-31251474

ABSTRACT

BACKGROUND: MEGDHEL is an autosomal recessive syndrome defined as 3-MEthylGlutaconic aciduria (3-MGA) with Deafness, Hepatopathy, Encephalopathy, and Leigh-like syndrome on magnetic resonance imaging, due to mutations in the SERAC1 (Serine Active Site Containing 1) gene, which plays a role in the mitochondrial cardiolipin metabolism. METHODS: We report the case of a young patient who presented with a convulsive encephalopathy, 3-methylglutaconic aciduria, deafness, and bilateral T2 hypersignals of the putamen and the thalami, who passed away at 8 years of age. RESULTS: Analysis of nuclear genes using an ampliSeq™ targeted custom panel disclosed two compound heterozygous variants in the SERAC1 gene: a nonsense substitution in exon 4, c.202C>T, resulting in a premature stop codon (p.Arg68*), and a novel variant at a canonical splicing site upstream exon 4 (c.129-1G>C). mRNAs sequencing from the fibroblasts of the patient showed that the splice site variant resulted in exon 3 skipping without frameshift while Western blot experiments showed the absence of SERAC1 expression compared to controls and abnormal filipin staining. CONCLUSION: We showed that the loss of the putative transmembrane domain of SERAC1, due to a novel splice site variant, impairs the protein expression and is responsible for the MEGDHEL syndrome.


Subject(s)
Brain Diseases/genetics , Carboxylic Ester Hydrolases/genetics , Deafness/genetics , Metabolism, Inborn Errors/genetics , Brain/diagnostic imaging , Brain Diseases/diagnosis , Child , Deafness/diagnosis , Exons/genetics , Fatal Outcome , Humans , Magnetic Resonance Imaging , Male , Metabolism, Inborn Errors/diagnosis , Pedigree , Protein Domains/genetics , RNA Splice Sites/genetics , Syndrome
3.
Ann Biol Clin (Paris) ; 74(6): 717-723, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27848923

ABSTRACT

After a short description of the structure and the physiological roles of unconjugated estriol, this paper points out pre-analytical conditions and performances of the serum unconjugated estriol immunoassay, essentially used for Down syndrome screening.


Subject(s)
Estriol/analysis , Estriol/immunology , Maternal Serum Screening Tests/statistics & numerical data , Down Syndrome/diagnosis , Estriol/chemistry , Female , Humans , Immunoassay/methods , Immunoassay/statistics & numerical data , Maternal Serum Screening Tests/methods , Maternal Serum Screening Tests/standards , Pregnancy
4.
Am J Hum Genet ; 92(4): 627-31, 2013 Apr 04.
Article in English | MEDLINE | ID: mdl-23561848

ABSTRACT

The Krebs cycle is of fundamental importance for the generation of the energetic and molecular needs of both prokaryotic and eukaryotic cells. Both enantiomers of metabolite 2-hydroxyglutarate are directly linked to this pivotal biochemical pathway and are found elevated not only in several cancers, but also in different variants of the neurometabolic disease 2-hydroxyglutaric aciduria. Recently we showed that cancer-associated IDH2 germline mutations cause one variant of 2-hydroxyglutaric aciduria. Complementary to these findings, we now report recessive mutations in SLC25A1, the mitochondrial citrate carrier, in 12 out of 12 individuals with combined D-2- and L-2-hydroxyglutaric aciduria. Impaired mitochondrial citrate efflux, demonstrated by stable isotope labeling experiments and the absence of SLC25A1 in fibroblasts harboring certain mutations, suggest that SLC25A1 deficiency is pathogenic. Our results identify defects in SLC25A1 as a cause of combined D-2- and L-2-hydroxyglutaric aciduria.


Subject(s)
Anion Transport Proteins/genetics , Brain Diseases, Metabolic, Inborn/etiology , Citric Acid/metabolism , Genes, Recessive , Mitochondria/metabolism , Mitochondrial Proteins/genetics , Mutation/genetics , Amino Acid Sequence , Biomarkers/analysis , Brain Diseases, Metabolic, Inborn/metabolism , Brain Diseases, Metabolic, Inborn/pathology , Case-Control Studies , Cells, Cultured , Chromatography, Liquid , Exome/genetics , Female , Fibroblasts/metabolism , Fibroblasts/pathology , Glutarates/urine , Humans , Male , Molecular Sequence Data , Organic Anion Transporters , Phenotype , Protein Structure, Tertiary , Retrospective Studies , Sequence Homology, Amino Acid , Stereoisomerism , Tandem Mass Spectrometry
5.
Clin Physiol Funct Imaging ; 32(4): 274-81, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22681604

ABSTRACT

Maximal exercise test with gas exchange measurement evaluates exercise capacities with maximal oxygen uptake (VO(2) max) measurement. Measurements of lactate (L), lactate/pyruvate ratio (L/P) and ammonium (A) during rest, exercise and recovery enhance interpretative power of maximal exercise by incorporating muscular metabolism exploration. Maximal exercise test with gas exchange measurement is standardized in cardiopulmonary evaluations but, no reference data of blood muscular metabolites are available to evaluate the muscular metabolism. We determined normal values of L, L/P and A during a standardized maximal exercise and recovery in 48 healthy sedentary volunteers and compared with results obtained in four patients with exercise intolerance and a mitochondrial disease. In healthy subjects, L, L/P and A rose during exercise. In 98% of them L, L/P or A decreased between the fifth and the fifteenth minutes of recovery. In mitochondrial patients, VO(2) max was normal or low, and L, L/P and A had the same evolution as normal subjects or showed no decrease during recovery. We gave normal L, L/P and A values, which establish references for a maximal exercise test with muscular metabolism exploration. This test is helpful for clinicians in functional evaluation, management and treatment of metabolic myopathy and would be a useful tool in diagnosis of metabolic myopathy.


Subject(s)
Energy Metabolism , Exercise , Muscle Contraction , Muscle, Skeletal/metabolism , Adult , Ammonia/blood , Biomarkers/blood , Exercise Test , Exercise Tolerance , Female , France , Heart Rate , Humans , Lactic Acid/blood , Male , Middle Aged , Mitochondrial Diseases/blood , Mitochondrial Diseases/physiopathology , Muscle, Skeletal/physiopathology , Muscular Diseases/blood , Muscular Diseases/physiopathology , Oxygen Consumption , Pyruvic Acid/metabolism , Recovery of Function , Time Factors
6.
JPEN J Parenter Enteral Nutr ; 30(1): 1-5, 2006.
Article in English | MEDLINE | ID: mdl-16387891

ABSTRACT

BACKGROUND: Jejunal nutrition is recommended during acute pancreatitis. The use of semi-elemental formulas presents several theoretical advantages over polymeric formulas, but their clinical value has been poorly documented. Our aim was to evaluate in patients with acute pancreatitis the effect of enteral nutrition by a semi-elemental formula compared with a polymeric formula. METHODS: A randomized prospective pilot study, stratified according to severity, was performed in 30 consecutive patients with acute pancreatitis requiring jejunal nutrition. The semi-elemental group received 35 kcal/kg/d of Peptamen (n = 15), and the polymeric group received the same quantity of Sondalis-Iso (n = 15). Tolerance was evaluated after 7 days of enteral nutrition (D7) on visual analog scale (VAS), stool frequency, and 24-hour steatorrhea/creatorrhea. Outcome was evaluated by weight loss, length of hospital stay, and infection rate. RESULTS: Results were calculated as mean +/- SEM, t-test, or chi2. Patients of the 2 groups were comparable in terms of age, gender, and severity. Tolerance was good in both groups (semi-elemental vs polymeric: VAS, 7.4 +/- 0.6 vs 7.1 +/- 0.6, not significant (NS); number of stools per 24 hours, 1.7 +/- 0.4 vs 1.8 +/- 0.4, NS). Steatorrhea and creatorrhea were lower than normal in both groups. In semi-elemental group, the length of hospital stay was shorter (23 +/- 2 vs 27 +/- 1, p = .006) and weight loss was less marked (1 +/- 1 vs 2 +/- 0, p = .01). One patient in semi-elemental group and 3 patients in polymeric group developed an infection (NS). CONCLUSIONS: Semi-elemental and polymeric nutrition are very well tolerated in patients with acute pancreatitis. Nutrition with a semi-elemental formula supports the hypothesis of a more favorable clinical course than nutrition with a polymeric formula, but this conclusion needs to be established in larger adequately powered clinical trials.


Subject(s)
Enteral Nutrition , Food, Formulated/analysis , Pancreatitis, Acute Necrotizing/therapy , Adult , Diarrhea/epidemiology , Diarrhea/etiology , Enteral Nutrition/adverse effects , Female , Humans , Length of Stay , Male , Middle Aged , Pilot Projects , Prospective Studies , Severity of Illness Index , Treatment Outcome , Weight Loss
7.
Biochem Biophys Res Commun ; 329(3): 1152-4, 2005 Apr 15.
Article in English | MEDLINE | ID: mdl-15752774

ABSTRACT

We describe a lethal mitochondrial disease in a 10-month-old child who presented with encephalomyopathy. Histochemical and electron microscopy examinations of skeletal muscle biopsy revealed abnormal mitochondria associated with a combined deficiency of complexes I and IV. After excluding mitochondrial DNA deletions and depletion, direct sequencing was used to screen for mutation in all transfer RNA (tRNA) genes. A T-to-C substitution at position 5693 in the tRNA(Asn) gene was found in blood and muscle. Microdissection of muscle biopsy and its analysis revealed the highest level of this mutation in cytochrome c oxidase (COX)-negative fibres. We suggest that this novel mutation would affect the anticodon loop structure of the tRNA(Asn) and cause a fatal mitochondrial disease.


Subject(s)
Cytochrome-c Oxidase Deficiency/genetics , Cytochrome-c Oxidase Deficiency/pathology , Electron Transport Complex IV/genetics , Genetic Predisposition to Disease/genetics , Mitochondria, Muscle/pathology , Muscle, Skeletal/pathology , RNA, Transfer, Asn/genetics , Cytochrome-c Oxidase Deficiency/complications , Humans , Infant , Male , Mitochondrial Encephalomyopathies/complications , Mitochondrial Encephalomyopathies/etiology , Mitochondrial Encephalomyopathies/genetics , Mitochondrial Encephalomyopathies/pathology , Mutation
8.
J Chromatogr B Analyt Technol Biomed Life Sci ; 781(1-2): 207-26, 2002 Dec 05.
Article in English | MEDLINE | ID: mdl-12450660

ABSTRACT

It is now widely accepted that increased total plasma homocysteine (tHcy) is a risk factor for cardiovascular disease. Hyperhomocysteinemia can be caused by impaired enzyme function as a result of genetic mutation or vitamin B (B(2), B(6), B(9), B(12)) deficiency. A lot of methods are now available for tHcy determination. High-pressure liquid chromatography (HPLC) with fluorescence detection are at present the most widely used methods but immunoassays, easier to use, begin to supplant in-house laboratory methods. In order to help with the choice of a main relevant homocysteine analytical method, the characteristics, performances and limits of the main current methods are reviewed. One major drawback among all these available methods is the transferability which is not clearly established to date. The impact of both inter-method and inter-laboratory variations on the interpretation of the tHcy results are discussed.


Subject(s)
Homocysteine/blood , Chromatography/methods , Electrophoresis, Capillary/methods , Female , Homocysteine/physiology , Humans , Immunoassay/methods , Male , Specimen Handling
SELECTION OF CITATIONS
SEARCH DETAIL
...